The global no-invasive blood glucose monitoring devices market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of diabetes and obesity in developing countries, which are driving the demand for non-invasive blood glucose monitoring devices.
The global no-invasive blood glucose monitoring devices market is segmented on the basis of type into MIR/NIR (mid/near infrared spectroscopy), Raman spectroscopy, occlusion spectroscopy, optical coherence tomography, photoacoustic spectroscopy and electromagnetic; by application into hospitals and clinics; and by region into North America, Latin America, Europe, Asia Pacific and Middle East & Africa.
- Increasing prevalence of diabetes and obesity in developing countries is driving the growth of the global Non-Invasive Blood Glucose Monitoring Devices market.
- The increasing number of people suffering from diabetes and obesity in developing countries is driving the growth of the global Non-Invasive Blood Glucose Monitoring Devices market.
- Increasing awareness about noninvasive blood glucose monitoring devices among patients with diabetes and obesity.
- Growing demand for noninvasive blood glucose monitoring devices from hospitals, clinics, and other healthcare facilities.
Industry Growth Insights published a new data on “Non-Invasive Blood Glucose Monitoring Devices Market”. The research report is titled “Non-Invasive Blood Glucose Monitoring Devices Market research by Types (MIR/NIR (Mid/Near Infrared Spectroscopy), Raman Spectroscopy, Occlusion Spectroscopy, Optical Coherence Tomography, Photoacoustic Spectroscopy, Electromagnetic, Fluorescence, Other), By Applications (Hospitals, Clinics, Home Care Settings, Other), By Players/Companies Abbott, BD Medical, Medtronic, Sanofi, Roche Diagnostics, Animas Technologies, Bayer Healthcare, Cercacor, Pendragon Medical, OrSense, Nova Biomedical, Dexcom, Terumo, Tosoh Bioscience”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Non-Invasive Blood Glucose Monitoring Devices Market Research Report
By Type
MIR/NIR (Mid/Near Infrared Spectroscopy), Raman Spectroscopy, Occlusion Spectroscopy, Optical Coherence Tomography, Photoacoustic Spectroscopy, Electromagnetic, Fluorescence, Other
By Application
Hospitals, Clinics, Home Care Settings, Other
By Companies
Abbott, BD Medical, Medtronic, Sanofi, Roche Diagnostics, Animas Technologies, Bayer Healthcare, Cercacor, Pendragon Medical, OrSense, Nova Biomedical, Dexcom, Terumo, Tosoh Bioscience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Non-Invasive Blood Glucose Monitoring Devices Market Report Segments:
The global Non-Invasive Blood Glucose Monitoring Devices market is segmented on the basis of:
Types
MIR/NIR (Mid/Near Infrared Spectroscopy), Raman Spectroscopy, Occlusion Spectroscopy, Optical Coherence Tomography, Photoacoustic Spectroscopy, Electromagnetic, Fluorescence, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care Settings, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- BD Medical
- Medtronic
- Sanofi
- Roche Diagnostics
- Animas Technologies
- Bayer Healthcare
- Cercacor
- Pendragon Medical
- OrSense
- Nova Biomedical
- Dexcom
- Terumo
- Tosoh Bioscience
Highlights of The Non-Invasive Blood Glucose Monitoring Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- MIR/NIR (Mid/Near Infrared Spectroscopy)
- Raman Spectroscopy
- Occlusion Spectroscopy
- Optical Coherence Tomography
- Photoacoustic Spectroscopy
- Electromagnetic
- Fluorescence
- Other
- By Application:
- Hospitals
- Clinics
- Home Care Settings
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Non-Invasive Blood Glucose Monitoring Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Non-invasive blood glucose monitoring devices are a type of medical device that use sensors to measure the level of glucose in a person's blood. These devices can be worn on the body, and they can send data about the person's blood sugar levels wirelessly to a receiver or computer. This information can help doctors diagnose and treat diabetes, and it can also help people monitor their own health over time.
Some of the major companies in the non-invasive blood glucose monitoring devices market are Abbott, BD Medical, Medtronic, Sanofi, Roche Diagnostics, Animas Technologies, Bayer Healthcare, Cercacor, Pendragon Medical, OrSense, Nova Biomedical, Dexcom, Terumo, Tosoh Bioscience.
The non-invasive blood glucose monitoring devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non-Invasive Blood Glucose Monitoring Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Non-Invasive Blood Glucose Monitoring Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Non-Invasive Blood Glucose Monitoring Devices Market - Supply Chain
4.5. Global Non-Invasive Blood Glucose Monitoring Devices Market Forecast
4.5.1. Non-Invasive Blood Glucose Monitoring Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Non-Invasive Blood Glucose Monitoring Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Non-Invasive Blood Glucose Monitoring Devices Market Absolute $ Opportunity
5. Global Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Type
5.3.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
5.3.2. Raman Spectroscopy
5.3.3. Occlusion Spectroscopy
5.3.4. Optical Coherence Tomography
5.3.5. Photoacoustic Spectroscopy
5.3.6. Electromagnetic
5.3.7. Fluorescence
5.3.8. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Home Care Settings
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Non-Invasive Blood Glucose Monitoring Devices Demand Share Forecast, 2019-2026
9. North America Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Home Care Settings
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Type
9.7.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
9.7.2. Raman Spectroscopy
9.7.3. Occlusion Spectroscopy
9.7.4. Optical Coherence Tomography
9.7.5. Photoacoustic Spectroscopy
9.7.6. Electromagnetic
9.7.7. Fluorescence
9.7.8. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Non-Invasive Blood Glucose Monitoring Devices Demand Share Forecast, 2019-2026
10. Latin America Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Home Care Settings
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Type
10.7.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
10.7.2. Raman Spectroscopy
10.7.3. Occlusion Spectroscopy
10.7.4. Optical Coherence Tomography
10.7.5. Photoacoustic Spectroscopy
10.7.6. Electromagnetic
10.7.7. Fluorescence
10.7.8. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Non-Invasive Blood Glucose Monitoring Devices Demand Share Forecast, 2019-2026
11. Europe Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Home Care Settings
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Type
11.7.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
11.7.2. Raman Spectroscopy
11.7.3. Occlusion Spectroscopy
11.7.4. Optical Coherence Tomography
11.7.5. Photoacoustic Spectroscopy
11.7.6. Electromagnetic
11.7.7. Fluorescence
11.7.8. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Non-Invasive Blood Glucose Monitoring Devices Demand Share, 2019-2026
12. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Home Care Settings
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Type
12.7.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
12.7.2. Raman Spectroscopy
12.7.3. Occlusion Spectroscopy
12.7.4. Optical Coherence Tomography
12.7.5. Photoacoustic Spectroscopy
12.7.6. Electromagnetic
12.7.7. Fluorescence
12.7.8. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Demand Share, 2019-2026
13. Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Home Care Settings
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Market Size and Volume Forecast by Type
13.7.1. MIR/NIR (Mid/Near Infrared Spectroscopy)
13.7.2. Raman Spectroscopy
13.7.3. Occlusion Spectroscopy
13.7.4. Optical Coherence Tomography
13.7.5. Photoacoustic Spectroscopy
13.7.6. Electromagnetic
13.7.7. Fluorescence
13.7.8. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Non-Invasive Blood Glucose Monitoring Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Non-Invasive Blood Glucose Monitoring Devices Market: Market Share Analysis
14.2. Non-Invasive Blood Glucose Monitoring Devices Distributors and Customers
14.3. Non-Invasive Blood Glucose Monitoring Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BD Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sanofi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche Diagnostics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Animas Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bayer Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cercacor
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pendragon Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. OrSense
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Nova Biomedical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Dexcom
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Terumo
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Tosoh Bioscience
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.1
